Studies report that TCF19 could promote cell proliferation and contribute to the malignant progression of cancer through mechanisms such as regulating WWC1, inhibiting FOXO1, or activating the ATK/FOXO1 signalling pathway [28, 29, 31]. Here, BTK is linked to cancer.